Raphael Pharmaceutical Inc. Quarterly Return On Equity in % from Q4 2021 to Q1 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Raphael Pharmaceutical Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q1 2023.
  • Raphael Pharmaceutical Inc. Return On Equity for the quarter ending March 31, 2023 was -8.99K %, a 329% decline year-over-year.
  • Raphael Pharmaceutical Inc. annual Return On Equity for 2022 was -5.07K %, a 181% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 -8.99K -6.89K -329% Jan 1, 2023 Mar 31, 2023
Q4 2022 -5.07K -11.3K -181% Oct 1, 2022 Dec 31, 2022
Q3 2022 -3.93K Jul 1, 2022 Sep 30, 2022
Q2 2022 -3.21K Apr 1, 2022 Jun 30, 2022
Q1 2022 -2.09K Jan 1, 2022 Mar 31, 2022
Q4 2021 6.25K Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.